ESR1 and breast carcinoma: The inhibition of ER expression or the loss of ER activity is related to TAM resistance, it is may be related to the mechanism by which ER mutations cause changes in ligand transcription levels to regulate breast cancer cell proliferation and induce TAM resistance [33, 34].